Plaintiffs' Counsel Moves Again in N.J. to Centralize Bextra and Celebrex Claims

TRENTON, N.J. - A second application has been made in New Jersey to centralize claims arising from injuries caused by the arthritis drug Bextra before a single judge. The application also asks the court to coordinate Celebrex-related cases under the state's Mass Tort Guidelines. Re: Application to Designate Bextra and Celebrex Litigation as a Consolidated Mass Tort, No. n/a (N.J. Sup. Ct.).

According to a Notice issued Sept. 26 by the Acting Administrative Director of the Courts, the application to designate Bextra and Celebrex Litigation as a consolidated mass tort would centralize all such state court claims in the Atlantic …